The Serotonin Connection

Journal of Orthomolecular Medicine

Volumn 11, Issue 1, 1996, Pages 35-44

  Nash, Robert A ^a  

^a Creative Medical Institute Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0039140412     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Alternative Medicine: Expanding Medical Horizons, A Report to the National Institutes of Health on Alternative Medical Systems and Practices in the United States, NIH Pub 94-060, GPO No. 017-040-00537-7, 1995.
2. Editorial, Where is the Wisdom. . .?,BMJ, Oct 5, 1991; 303-798.
3. Eisenberg D et al: Unconventional Medicine in the United States, NEJM, Jan 28, 1993; 238: 246-252.
4. Travell J: Advances in Pain Research and Therapy, Vol 1, Myofascial Trigger Points: Clinical Views, New York. Raven Press, 1976.
5. Travel J & Simons D: Myofascial Pain and Dysfunction, The Trigger Point Manual. Baltimore. Williams & Wilkins. 1983.
6. Travell J & Simons D: Myofascial Pain and Dysfunction, The Trigger Point Manual. The Lower Extremities: 2. Baltimore. Williams & Wilkins. 1992.
7. Fricton JR & Awad EA: Myofascial Pain and Fibromyalgia. Advances in Pain Research and Therapy, New York. Raven Press. 1990; 17.
8. Moldofsky H: Sleep-Wake Mechanisms in Fibrositis. J of Rheumatology, 1989; 16 Suppl 19: 47-48.
9. Moldofsky H: Pain and Sleep, presented at Sleep Disorders Conf. Phoenix, AZ, 1992.
10. Moldofsky H, Lullis C, Lue FA: Sleep Related Myoclonus in Rheumatic Pain Modulation Disorder (Fibrositis Syndrome). J of Rheumatology, 1986; 13: 614-617.
11. Moldofsky H, Saskin P, Lue FA: Sleep and Symptoms in Fibrositis Syndrome After a Febrile Illness. J of Rheumatology, 1988; 15: 1701-1704.
12. Fields H: Pain, New York. McGraw-Hill. 1987.
13. Journal of Musculoskeletal Pain, 1993; 2: 3,4.
14. Paul S: Anxiety and Depression: A common Neurophysiological Substrate? Journal of Clinical Psychology, 1988; 10: 13-16.
15. The National Report on Substance Abuse, Dec 2, 1992; 7,1: 1-2.
16. The National Report on Substance Abuse, Dec 2, 1992; 7:1,5.
17. Drug Abuse in the United States, Strategies far Prevention, JAMA, 1991; 265: 2202-2104.
18. Blum K. et al: Allelic Association of Human Dopamine D2 Receptor Gene in Alcoholism, JAMA, 1990; 263: 2055-2060.
19. Noble E & Blum: K 〈〉 Letters, JAMA, 1991; 265-267.
20. Suzdak P, et al: Ethanol Stimulates Gamma-Amino Butyric Acid Receptor - Mediated Chloride Transport in Rat Brain Synaptoneurosomes.
21. Ibid. ref. 27.
22. Greenblat D, Shader R, Abernathy D: Current Status of Benzodiazepines. NEJM, 1983; 309: 354-358.
23. Nash RA: Use of Energy Medicine in Drug Treatment. New Frontiers in Drug Policy, Drug Policy Foundation. 1991; 250-255.
24. From the Alcohol Drug Abuse and Mental Health Administration. JAMA, 1991; 265-2657.
25. Pope H, et al: Valproate in the Treatment of Acute Mania. Arch Gen Psychiatry, 1991; 48: 62-68.
26. Emerick H, et al: Therapeutic Effects of GABA-ergic Drugs in Affective Disorders: A Preliminary Report. Pharmacology, Biochemistry and Behavior, 1983; 19: 369-372.
27. McElroy S, et al: Sodium Valproate: Its use in Primary Psychiatric Disease. Journal of Clinical Psychopharmacology,1987; 7:16-24.
28. Clinical Neurology, Joynt RJ, editors. Philidelphia. J.B. Lippincott. 1994; 2: 1-81.
29. Pomeranz B: Recent Advances in Acupuncture Research, Temple Univ. Center for Frontier Sciences Symposium. Apr 26, 1994.
30. Microwave News, 1990; 10: 9-10
31. Wilson B, et al: Chronic Exposure to 60 Hz Electric Fields: Effects on Pineal Function in the Rat. Bioelectromagnetics,1991; 2: 371-380.
32. Wilson B, et al: Neuroendocrine Mediated Effects of the Electromagnetic Field Exposure: Possible Role of the Pineal Gland, Life Sciences,1989; 45: 1319-1332.
33. Shealy CN, et al: Depression, A Diagnostic Neurochemical Profile and Therapy with Cranial Electric Stimulation. Journal of Neurological and Orthopedic Medicine and Surgery, 1989; 20: 319-321.
34. Patterson MA: Treatment of Drug, Alcohol and Nicotine Addiction by Neuroelectric Therapy Analysis of Results over Seven Years. J of Bioelectricity, 1987; 31: 195-221.
35. Severson L, et al: Heroin Detoxification with Acupuncture and Electrical Stimulation copyright by Marcel Whitehead, 1977.
36. Acupuncture in the Treatment of Addiction, A Review and Analysis, The International Journal of Addiction, 1978; 13: 1-16.
37. International Medical Acupuncture Review
38. Engelberg H: Low Serum Cholesterol and Suicide. Lancet, 1992; 339: 727-729.
39. Drislane FW, et al: Myocardial Contraction Band Lesions in Patients with Fatal Asthma: Possible Neurocardiologic Mechanisms. Amer Review of Resp Distress, 1978; 498-501.
40. Kawachi I, et al: Symptoms of Anxiety and Risk of Coronary Heart Disease, The Normative Aging Study. Circulation, 1994; 3: 2225-2229.
41. Kawachi I, et al: Prospective Study of Phobic Anxiety and Risk of Coronary Heart Disease Men. Circulation, 1994; 89:1992-1997.
42. Wysowski DK & Gross TP: Deaths due to Accidents and Violence in Two Recent Trials of Cholesterol-Lowering Drugs. Arch Inter Med, 1990; 150: 2169-2172.
43. Muldoon MF, Manuck SB, Matthews KA: Lowering Cholesterol Concentrations and Mortality: A Quantitative Review of Primary Prevention Trials. BMJ, 1990; 301: 309-314.
44. Engelberg H: Low Serum Cholesterol and Suicide. The Lancet, 1992; 339: 727-729.
45. Leonard B, et al: Focus on SSRI: Broadening the Spectrum of Clinical Use. J of Clinical Psychiatry, 1994; 54: 1-8.
46. Putt RB & Woldman SD: Serotonin, Sumatriptan and Headache, APS Bulletin, 1994; 7: 13-15.
47. The Journal of Clinical Psychiatry, 1985; 46: 3-67.
48. Fava M, et al: Neurochemical Abnormalities of Anorexia Nervosa and Bulimia Nervosa, Amer J Psychiatry, 1989; 146: 962-971.
49. Buckner ET: Do You have Patients with Anorexia or Bulimia: Understanding is the First Step in Helping. Postgrad Med, 199; 89: 209-212, 215.
50. Fluoxetine in the Treatment of Bulimia Nervosa, A Multicenter, Placebo Controlled, Double-Blind Trial. Arch of Clinical Psychiatry, 1992; 49: 139-147.
51. Akunne HC & Soliman KF: Serotonin Modulation of Pain Responsiveness in the Aged Rat, Pharmacology, Biochemistry and Behavior, 1994; 48: 411-416.
52. Cross SA: Pathophysiology of Pain. Mayo Clinic Proc, 1994; 69: 375-383.
53. Power-Smith P & Turkington D: Fluoxetine in Phantom Limb Pain. Br J Psychiatry, 1993; 105-106.
54. Hirsch AR, et al: Fluoxetine HCl in the Treatment of Chronic Pain Syndromes. Headache Quarterly, 1994; 4: 350-351.
55. Goldstein DJ, et al: Fluoxetine: A Randomized Clinical Trial in the Treatment of Obesity. 1994; 18: 129-135.
56. Schneier FR, et al: Fluoxetine in Panic Disorder. J. Clinical Psychopharmacology, 1990; 10: 119-121.
57. Naranjo CA, et al: Fluoxetine Differentially Alters Alcohol Intake and Other Consummatory Behaviors in Problem Drinkers, Clinical Pharmacology and Therapeutics, 1990; 490-498.
58. Richels K, et al: Fluoxetine in the Treatment of Premenstrual Syndrome, Current Therapeutic Research,1990; 48: 161-166.
59. Brown CS &: Cooke SC: Attention-Deficit Hyperactivity Disorder - Clinical Features and Treatment Options. CNS Drugs, 1994; 1: 95-106.
60. March JS: Fluoxetine and Fluvoxamine in Post Traumatic Stress Disorder. Am J Psychiatry, 1992; 149: 413.
61. Amit Z, et al: Serotonin Uptake Inhibitors: Effects on Motivated Consummatory Behaviors. J Clinical Psychiatry, 1991; 52 suppl: 55-60.
62. Roy A, et al: Fluoxetine Treatment of Post Partum Depression. Am J Psychiatry, 1993; 150: 1273.
63. Sichel DA, et al: Post Partum OCD: A Case Series. J Clinical Psychiatry, 1993; 54; 156-159.
64. Patterson M, et al: Neuroelectric Therapy (NET) in Addiction Detoxification. Subtle Energies, 1993; 3: 1-23.
65. Kutz I, Borysenko J, Benson H: Meditation and Psychotherapy: A Rationale for the Integration of Dynamic Psychotherapy, The Relaxation Response, and Mindfulness Meditation. Am J Psychiatry, 1985; 142: 1-8.
66. Mellion M: Exercise Therapy for Anxiety and Depression. Postgrad Med, 1985; 77: 59-63, 91-98.
67. Whitehead P: Acupuncture in the Treatment of Addiction: A Review and Analysis. The Inter J of Addictions, 1979; 13: 1-16.
68. Megabrain Report. The Journal of Optimal Performance, 1995; 2: 4.
69. Peniston E G, Kulkosky P J: Alpha Theta Brainwave Neuro-Feedback for Vietnam Veterans with Combat Related Post-Traumatic Stress Disorders. Medical Psychotherapy, 1991; 4: 1-14.
70. Biological Effects of Power Frequency Electric and Magnetic Fields. Office of Technology Assessment, Congress of the United States, GPO, No. 052-003-01152-2, 1989.